Effects of Class III Elastics on Stability of Orthopaedic Class III Correction
Launched by SYDNEY LOCAL HEALTH DISTRICT · May 27, 2021
Trial Information
Current as of July 04, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Over the years many types of appliances have been recommended for retaining Class III correction in growing children such as intermaxillary splints, class III activator, Frankel 3, Class III twin block, continued use of face-mask and chin-cup. However, currently none of these are in routine use and there is no evidence on the long term effectiveness of any retention protocol for class III correction.
One of the most commonly used retainers following orthodontic treatment is clear plastic retainers. There are no studies that investigated whether using class III elastics in combination with ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients that completed their orthodontic treatment for the management of their skeletal class III with upper jaw retrusion that was treated with Class III orthopaedic appliances, followed by full fixed appliances.
- • No congenital anomalies or craniofacial syndromes
- • No other orthodontic treatment
- • No medical history that effects growth
- Exclusion Criteria:
- • Congenital anomalies or craniofacial syndromes
- • Other orthodontic treatment
- • Medical history that effects growth
About Sydney Local Health District
Sydney Local Health District (SLHD) is a leading healthcare organization dedicated to providing high-quality medical services and advancing health research in the Sydney region. As a prominent sponsor of clinical trials, SLHD focuses on innovative treatments and evidence-based practices to improve patient outcomes. With a commitment to ethical standards and patient safety, SLHD collaborates with healthcare professionals, researchers, and academic institutions to facilitate groundbreaking studies that contribute to the global medical community. Its comprehensive approach ensures that clinical trials are conducted efficiently, fostering advancements in healthcare that benefit both local and broader populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chatswood, New South Wales, Australia
Surry Hills, New South Wales, Australia
Patients applied
Trial Officials
Oyku Dalci, DDS, PhD
Principal Investigator
Sydney Local Health District, The University of Sydney
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials